To be a tumor promoting or tumor suppressing ILC: That is the question

Semin Immunol. 2019 Feb:41:101283. doi: 10.1016/j.smim.2019.101283. Epub 2019 Jul 20.

Author

Camilla Jandus¹

Affiliation

¹ Department of Oncology and Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. Electronic address: Camilla.Jandus@chuv.ch.

PMID: 31337579
DOI: 10.1016/j.smim.2019.101283

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Cytotoxicity, Immunologic
Disease Susceptibility
Humans
Immunity, Innate*
Immunomodulation*
Lymphocytes / immunology*
Lymphocytes / metabolism*
Neoplasms / etiology*
Neoplasms / metabolism*
Neoplasms / pathology